It is a synthetic ethyl-cyclohexanol derivative used for the treatment of depression.

Market Analysis and Insights: Global Venlafaxine Hydrochloride Market
The global Venlafaxine Hydrochloride market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Venlafaxine Hydrochloride Scope and Market Size
The global Venlafaxine Hydrochloride market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Venlafaxine Hydrochloride market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Above 98%
Below 98%

Segment by Application
Tablet
Capsule
Other

The Venlafaxine Hydrochloride market is analysed and market size information is provided by regions (countries). Segment by Application, the Venlafaxine Hydrochloride market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Mesha Pharma
Sun Pharmaceutical Industries
Taj API
Synergy Pharmaceutical
Winsunny Harmony Science & Technology
Suzhou No.4 Pharmaceutical Factory